|Day Low/High||11.60 / 12.76|
|52 Wk Low/High||10.32 / 29.97|
This downward action in the small biotech sector tends to happen often in the 'dog days' of summer.
France-based firm said its Phase 2 study of eryaspase (Graspa) in acute myeloid leukemia did not achieve its primary endpoint of overall survival.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said Radius Health is a takeover target.
Been two fairly uneventful days of trading, as far as the market indexes go, sitting in for Doug Kass here on the Daily Diary. Major indices are slightly down as we head into the last two hours of the trading week. Getting a few questions on Radius ...
Shares of the biopharmaceutical company appear no closer to a bottom.
Jim Cramer, The Street's Action Alerts PLUS Portfolio Manager and host of CNBC's 'Mad Money,' said Allergan (AGN) is a stock to hold onto.
Jim Cramer says Microsoft (MSFT) will report a decent quarter, thanks to Windows 10, but he wishes the company would make an acquisition.
These stocks will be up so high today, that many fans will say "no thanks."
Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange. He weighs in on Apple (AAPL), Alcoa (AA), Walgreens (WBA), Disney (DIS) and more.
Jim Cramer likes Soutwest (LUV), isn't a fan of Sarepta Therapeutics (SRPT) and will soon have a 'surprise' piece on McDonald's (MCD).
And now he's in electioneering mode at its worst.
I wonder why skepticism disappears so quickly these days.
Sequential Brands (SQBG) and Martha Stewart Living Omnimedia (MSO) rocketed higher by late afternoon Thursday.
Jim Cramer answers viewers' stock questions from the floor of the New York Stock Exchange.
IPO Desktop President Francis Gaskins believes investors should wait until these biotech offerings prove they are healthy.